Company / Depreciation & Amortization
LIPELLA PHARMACEUTICALS INC. Depreciation & Amortization History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.9K
FY2024
5-year range
$1.7K / $2.9K
FY2023-FY2024
Trend
+71.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2,886 in FY2024.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, depreciation & amortization increased 71.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.9K | +71.3% |
| FY2023 | $1.7K | - |
| FY2022 | - | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026